| Product Information |
|
| Registration Number |
DRP-11162-01
|
| Generic Name |
Piperacillin (as sodium) + Tazobactam (as sodium)
|
| Brand Name |
Nosamax 4.5
|
| Dosage Strength |
4g/500mg
|
| Dosage Form |
Powder for Injection (I.V.)
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
| Packaging |
USP Type II Moulded Glass Vial with Butyl Rubber Stopper and Blue Flip-off Cap + Sterile Water for Injection as Diluent in 10mL USP Type I Clear and Colorless Glass Ampoule (Box of 1 Vial + 2 Ampoules)
|
| Manufacturer |
Reyoung Pharmaceutical Co., Ltd.
|
| Country of Origin |
China
|
| Trader |
N/A
|
| Importer |
Dreamax Incorporated
|
| Distributor |
Dreamax Life Sciences Incorporated
|
| Application Type |
CLIDP Conversion
|
| Issuance Date |
27 July 2022
|
| Expiry Date |
08 February 2027
|